Skip to main
RXST

RxSight (RXST) Stock Forecast & Price Target

RxSight (RXST) Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 11%
Buy 0%
Hold 67%
Sell 22%
Strong Sell 0%

Bulls say

RxSight Inc. has demonstrated solid growth and operational stability, with a reported revenue increase that surpassed consensus expectations, indicating effective business strategies and strong demand for its light adjustable lenses. The company’s management has taken a more strategic approach to product placements, focusing on initiatives designed to enhance customer engagement and drive higher volumes, which contributes to a robust outlook for future revenue growth. Additionally, the raised gross margin guidance to 76-77% reflects improved operational efficiency and potential for significant profitability, while ongoing factors such as faster installed base growth and better product utilization serve as positive indicators for RxSight's financial performance moving forward.

Bears say

RxSight Inc. has experienced a notable decline in key performance metrics, particularly in monthly utilization rates of light adjustable lenses (LALs), which dropped to 8.0 per lens delivery device (LDD) in 3Q25 from 8.7 in 2Q25 and 10.1 in 3Q24. The company's fiscal guidance for FY2026 revenue is projected to be between $120M and $135M, representing a decrease of 11% to flat year-over-year, which falls short of previous market expectations. Additionally, while operating expenses decreased slightly to $36.6M year-over-year, the impending impact of higher-cost inventory on gross margins is anticipated to contribute to further sequential revenue contraction through the end of 2026.

RxSight (RXST) has been analyzed by 9 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 0% recommend Buy, 67% suggest Holding, 22% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About RxSight (RXST) Forecast

Analysts have given RxSight (RXST) a Hold based on their latest research and market trends.

According to 9 analysts, RxSight (RXST) has a Hold consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

RxSight (RXST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.